New York State Teachers Retirement System Increases Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

New York State Teachers Retirement System increased its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 3.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 130,786 shares of the company’s stock after buying an additional 4,212 shares during the period. New York State Teachers Retirement System owned about 0.15% of Pediatrix Medical Group worth $1,716,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in MD. CWM LLC boosted its holdings in Pediatrix Medical Group by 134.0% during the 3rd quarter. CWM LLC now owns 6,427 shares of the company’s stock valued at $74,000 after acquiring an additional 3,681 shares during the period. Creative Planning increased its position in Pediatrix Medical Group by 48.3% during the third quarter. Creative Planning now owns 30,662 shares of the company’s stock worth $355,000 after buying an additional 9,991 shares during the period. Nisa Investment Advisors LLC increased its position in Pediatrix Medical Group by 352.4% during the third quarter. Nisa Investment Advisors LLC now owns 21,513 shares of the company’s stock worth $249,000 after buying an additional 16,758 shares during the period. Principal Financial Group Inc. increased its holdings in shares of Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock valued at $5,953,000 after purchasing an additional 63,581 shares during the period. Finally, Atria Investments Inc increased its holdings in shares of Pediatrix Medical Group by 9.0% in the third quarter. Atria Investments Inc now owns 27,124 shares of the company’s stock valued at $314,000 after purchasing an additional 2,238 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Truist Financial upped their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday. Jefferies Financial Group upped their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft upped their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a report on Monday, November 4th. Mizuho upped their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th. Finally, Macquarie assumed coverage on Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price on the stock. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.08.

Pediatrix Medical Group Price Performance

Shares of NYSE MD opened at $15.57 on Friday. The firm has a market cap of $1.34 billion, a PE ratio of -12.97, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. The business has a 50 day moving average price of $13.89 and a two-hundred day moving average price of $12.99. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.